Erratum: Effects of isoflavones equol and genistein on bone quality in a rat osteopenia model (Phytotherapy Research (2010) 24, Supplement 2 DOI: 10.1002/ptr.3060);Effects of isoflavones equol and genistein on bone quality in a rat osteopenia model

Phytotherapy Research

Volumn 24, Issue SUPPL. 2, 2010, Pages

  Sehmisch, S ^a   Erren, M ^a   Kolios, L ^a   Tezval, M ^a   Seidlova Wuttke, D ^a   Wuttke, W ^a   Stuermer, K M ^a   Stuermer, E K ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Biomechanical testing; Equol; Genistein; Microstructural analysis; Osteoporosis

Indexed keywords

EQUOL; ESTRADIOL BENZOATE; GENISTEIN; ISOFLAVONE; OSTEOCALCIN; PHYTOESTROGEN; 4',7-DIHYDROXY-3,4-DIHYDROISOFLAVONE; ESTRADIOL; ISOFLAVONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE; BONE STRENGTH; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE SUBSTITUTION; LOADING TEST; LUMBAR SPINE; MICRORADIOGRAPHY; MODEL; NONHUMAN; OSTEOPENIA; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN BLOOD LEVEL; RAT; TREATMENT OUTCOME; VERTEBRA BODY; ANIMAL; BLOOD; BONE DISEASES, METABOLIC; COMPARATIVE STUDY; COMPRESSIVE STRENGTH; DRUG EFFECTS; PHYSIOLOGY;

RATTUS;

ANIMALS; BIOMECHANICAL PHENOMENA; BONE AND BONES; BONE DISEASES, METABOLIC; COMPRESSIVE STRENGTH; EQUOL; ESTRADIOL; FEMALE; GENISTEIN; ISOFLAVONES; OSTEOCALCIN; OVARIECTOMY; PHYTOESTROGENS; RATS;

EID: 77953881925     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3253     Document Type: Erratum

References (35)

1. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. 2002. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72: 844-852. (Pubitemid 30667108)
2. Anderson JJ, Garner SC. 1998. Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 12: 543-557.
3. Basly JP, Lavier MC. 2005. Dietary phytoestrogens: potential selective estrogen enzyme modulators? Planta Med 71: 287-94.
4. Dai R, Ma Y, Sheng Z, Jin Y, Zhang Y, Fang L, Fan H, Liao E. 2008. Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats. J Bone Miner Metab 26: 342-349. (Pubitemid 351953024)
5. Fujioka M, Uehara M, Wu J, Adlercreutz H, Suzuki K, Kanazawa K, Takeda K, Yamada K, Ishimi Y. 2004. Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice. J Nutr 134: 2623-2627. (Pubitemid 39315263)
6. Genant HK, Delmas PD, Chen P, Jiang Y, Eriksen EF, Dalsky GP, Marcus R, San Martin J. 2007. Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int 18: 69-76. (Pubitemid 44885497)
7. Hegsted DM. 1986. Calcium and osteoporosis. J Nutr 116: 2316-2319.
8. Hertrampf T, Degen GH, Kaid AA, Laudenbach-Leschowsky U, Seibel J, Di Virgilio AL, Diel P, 2006. Combined effects of physical activity, Dietary isoflavones and 17β-estradiol on movement drive, body weight and bone mineral density in ovariectomized female rats. Planta Med 72: 484-7. (Pubitemid 43844673)
9. Hertrampf T, Gruca MJ, Seibel J, Laudenbach U, Fritzemeier KH, Diel P. 2007. The bone-protective effect of the phytoestrogen genistein is mediated via ER alpha-dependent mechanisms and strongly enhanced by physical activity. Bone 40: 1529-35. (Pubitemid 46779003)
10. Holmes P, Rumsby P, Harrison PT. 2004. Endocrine disrupters and menopausal health. J Br Menopause Soc 10: 54-59.
11. Hotchkiss CE, Weis C, Blaydes B, Newbold R, Delclos KB. 2005. Multigenerational exposure to genistein does not increase bone mineral density in rats. Bone 37: 720-727. (Pubitemid 41476395)
12. Humpel M, Isaksson P, Schaefer O, Kaufmann U, Ciana P, Maggi A, Schleuning WD, 2005. Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus. J Steroid Biochem Mol Biol 97: 299-305. (Pubitemid 41607581)
13. Ikeda S, Tsurukami H, Ito M, Sakai A, Sakata T, Nishida S, Takeda S, Shiraishi A, Nakamura T. 2001. Effect of trabecular bone contour on ultimate strength of lumbar vertebra after bilateral ovariectomy in rats. Bone 28: 625-633. (Pubitemid 32577379)
14. Kolios L, Sehmisch S, Daub F, Rack T, Tezval M, Stuermer KM, Stuermer EK. 2009. Influence of the isoflavonic phytohormones equol and genistein as well as estrogen on metaphyseal bone healing in the osteoporotic rat. Planta Med. In press.
15. Li W, Seifert M, Xu Y, Hock B. 2004. Comparative study of estrogenic potencies of estradiol, tamoxifen, bisphenol-A and resveratrol with two in vitro bioassays. Environ Int 30: 329-335 (Pubitemid 38232867)
16. Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. 2005. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women. Osteoporos Int 16: 372-379. (Pubitemid 40487394)
17. Mueller SO, Simon S, Chae K, Metzler M, Korach KS. 2004. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80: 14-25. (Pubitemid 38967392)
18. Pacifici R. 1998. Cytokines, estrogen, and postmenopausal osteoporosis-the second decade. Endocrinology 139: 2659-2661.
19. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610.
20. Phrakonkham P, Chevalier J, Desmetz C, Pinnert MF, Bergès R, Jover E, Davicco MJ, Bennetau-Pelissero C, Coxam V, Artur Y, Canivenc-Lavier MC. 2007. Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats. Toxicol Appl Pharmacol 224: 105-115.
21. Rachoń D, Seidlová-Wuttke D, Vortherms T, Wuttke W. 2007a. Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats. Maturitas 58: 308-315. (Pubitemid 350086841)
22. Rachoń D, Vortherms T, Seidlová-Wuttke D, Menche A, Wuttke W. 2007b. Uterotropic effects of dietary equol administration in ovariectomized Sprague-Dawley rats. Climacteric 10: 416-426. (Pubitemid 47402937)
23. Rickard DJ, Monroe DG, Ruesink TJ, Khosla S, Riggs BL, Spelsberg TC. 2003. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta. J Cell Biochem 89: 633-646.
24. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-33.
25. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. 2000. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36: 27-32.
26. Sathyamoorthy N, Wang TT. 1997. Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur J Cancer 33: 2384-2389. (Pubitemid 28129181)
27. Sehmisch S, Boeckhoff J, Wille J, Seidlova-Wuttke D, Rack T, Tezval M, Wuttke W, Stuermer KM, Stuermer EK. 2008a. Vitex agnus castus as prophylaxis for osteopenia after orchidectomy in rats compared with estradiol and testosterone supplementation. Phytother Res 2009 Jun; 23(6): 851-858.
28. Sehmisch S, Hammer F, Christoffel J, Seidlova-Wuttke D, Tezval M, Wuttke W, Stuermer KM, Stuermer EK. 2008b. Comparison of the phytohormones genistein, resveratrol and 8-prenylnaringenin as agents for preventing osteoporosis. Planta Med 74: 794-801.
29. Setchell KD, Brown NM, Lydeking-Olsen E. 2002. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132: 3577-3584. (Pubitemid 35435031)
30. Setchell KD, Cole SJ. 2006. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 136: 2188-2193.
31. Siris E, Adachi JD, Lu Y, Fuerst T, Crans GG, Wong M, Harper KD, Genant HK. 2002. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation. Osteoporos Int 13: 907-913.
32. Stürmer EK, Seidlová-Wuttke D, Sehmisch S, Rack T, Wille J, Frosch KH, Wuttke W, Stürmer KM. 2006. Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene. J Bone Miner Res 2006 Jan; 21(1): 89-96. Epub 2005 Sep 26.
33. Tsuang YH, Chen LT, Chiang CJ, Wu LC, Chiang YF, Chen PY, Sun JS, Wang CC. 2008. Isoflavones prevent bone loss following ovariectomy in young adult rats. J Orthop Surg Res 3:12.
34. Weaver CM, Cheong JM. 2005. Soy isoflavones and bone health: the relationship is still unclear. J Nutr 135: 1243-1247. (Pubitemid 40638336)
35. Yamagishi T, Otsuka E, Hagiwara H. 2001. Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis. Endocrinology 142: 3632-3637.